Considering maternal dietary modulators for epigenetic regulation and programming of the fetal epigenome

Nutrients

Volumn 7, Issue 4, 2015, Pages 2748-2770

  Chango, Abalo ^a   Pogribny, Igor P ^b  

^a INSTITUT POLYTECHNIQUE LASALLE BEAUVAIS   (France)

^b NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

Author keywords

DNA methylation; Epigenetics; Histone; Maternal diet; MicroRNAs; Programming

Indexed keywords

ARGININE; CATECHOL METHYLTRANSFERASE; CYANOCOBALAMIN; CYCLIN D2; CYTOSINE; EPIGALLOCATECHIN GALLATE; GENOMIC DNA; GLUTATHIONE TRANSFERASE P1; HISTONE ACETYLTRANSFERASE; LYSINE; METHYL GROUP; MICRORNA; RESVERATROL; RETINOID RELATED ORPHAN RECEPTOR BETA; RETINOID RELATED ORPHAN RECEPTOR BETA 2; UNCLASSIFIED DRUG; CARBOHYDRATE DIET; FAT INTAKE; PROTEIN INTAKE; TRACE ELEMENT;

CARBON METABOLISM; DNA METHYLATION; DNA SEQUENCE; EPIGENETICS; FOLIC ACID DEFICIENCY; FOOD QUALITY; FOOD SAFETY; GENE CONTROL; GENE EXPRESSION; GENE REPRESSION; GENETIC TRANSCRIPTION; GENOMIC INSTABILITY; HISTONE MODIFICATION; HUMAN; MACRONUTRIENT; MATERNAL NUTRITION; MODERN DIET; NUTRITIONAL ASSESSMENT; PHENOTYPE; REVIEW; X CHROMOSOME INACTIVATION; ADMINISTRATION AND DOSAGE; CALORIC INTAKE; CARBOHYDRATE DIET; DIET; FAT INTAKE; FEMALE; FETUS; GENETIC EPIGENESIS; PHYSIOLOGY; PREGNANCY; PROTEIN INTAKE;

DIET; DIETARY CARBOHYDRATES; DIETARY FATS; DIETARY PROTEINS; ENERGY INTAKE; EPIGENESIS, GENETIC; EPIGENOMICS; FEMALE; FETUS; HUMANS; MICRONUTRIENTS; PREGNANCY; PRENATAL NUTRITIONAL PHYSIOLOGICAL PHENOMENA;

EID: 84927932889     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu7042748     Document Type: Review

References (144)

1. Baylin, S.B.; Jones, P.A. A decade of exploring the cancer epigenome-biological and translational implications. Nat. Rev. Cancer 2011, 11, 726-734.
2. Rodenhiser, D.; Mann, M. Epigenetics and human disease: Translating basic biology into clinical applications. CMAJ 2006, 174, 341-348.
3. Hewagama, A.; Richardson, B. The genetics and epigenetics of autoimmune diseases. J. Autoimmun. 2009, 33, 3-11.
4. Lopez-Pedrera, C.; Perez-Sanchez, C.; Ramos-Casals, M.; Santos-Gonzalez, M.; Rodriguez-Ariza, A.; Cuadrado, M.J. Cardiovascular risk in systemic autoimmune diseases: Epigenetic mechanisms of immune regulatory functions. Clin. Dev. Immunol. 2012, 2012, doi:10.1155/2012/974648.
5. Barres, R.; Zierath, J.R. DNA methylation in metabolic disorders. Am. J. Clin. Nutr. 2011, 93, 897S-900S.
6. Brookes, E.; Shi, Y. Diverse epigenetic mechanisms of human disease. Annu. Rev. Genet. 2014, 48, 237-268.
7. Gaudet, F.; Hodgson, J.G.; Eden, A.; Jackson-Grusby, L.; Dausman, J.; Gray, J.W.; Leonhardt, H.; Jaenisch, R. Induction of tumors in mice by genomic hypomethylation. Science 2003, 300, 489-492.
8. Reik, W.; Dean, W.; Walter, J. Epigenetic reprogramming in mammalian development. Science 2001, 293, 1089-1093.
9. Smith, Z.D.; Meissner, A. DNA methylation: Roles in mammalian development. Nat. Rev. Genet. 2013, 14, 204-220.
10. Saffery, R.; Novakovic, B. Epigenetics as the mediator of fetal programming of adult onset disease: What is the evidence? Acta Obstet. Gynecol. Scand. 2014, 93, 1090-1098.
11. Jiang, X.; West, A.A.; Caudill, M.A. Maternal choline supplementation: A nutritional approach for improving offspring health? Trends Endocrinol. Metab. 2014, 25, 263-273.
12. Masuyama, H.; Hiramatsu, Y. Effects of a high-fat diet exposure in utero on the metabolic syndrome-like phenomenon in mouse offspring through epigenetic changes in adipocytokine gene expression. Endocrinology 2012, 153, 2823-2830.
13. Thornburg, K.L.; Shannon, J.; Thuillier, P.; Turker, M.S. In utero life and epigenetic predisposition for disease. Adv. Genet. 2010, 71, 57-78.
14. Hogg, K.; Price, E.M.; Hanna, C.W.; Robinson, W.P. Prenatal and perinatal environmental influences on the human fetal and placental epigenome. Clin. Pharmacol. Ther. 2012, 92, 716-726.
15. Mathers, J.C. Early nutrition: Impact on epigenetics. Forum Nutr. 2007, 60, 42-48.
16. Szyf, M. The early life environment and the epigenome. Biochim. Biophys. Acta 2009, 1790, 878-885.
17. Sharma, S.; Kelly, T.K.; Jones, P.A. Epigenetics in cancer. Carcinogenesis 2010, 31, 27-36.
18. Bell, J.T.; Pai, A.A.; Pickrell, J.K.; Gaffney, D.J.; Pique-Regi, R.; Degner, J.F.; Gilad, Y.; Pritchard, J.K. DNA methylation patterns associated with genetic and gene expression variation in HapMap cell lines. Genome Biol. 2011, 12, doi:10.1186/gb-2011-12-1-r10.
19. Pogribny, I.P.; Rusyn, I. Environmental toxicants, epigenetics, and cancer. Adv. Exp. Med. Biol. 2013, 754, 215-232.
20. Fraga, M.F.; Ballestar, E.; Paz, M.F.; Ropero, S.; Setien, F.; Ballestar, M.L.; Heine-Suñer, D.; Cigudosa, J.C.; Urioste, M.; Benitez, J.; et al. Epigenetic differences arise during the lifetime of monozygotic twins. Proc. Natl. Acad. Sci. USA 2005, 102, 10604-10609.
21. Talens, R.P.; Boomsma, D.I.; Tobi, E.W.; Kremer, D.; Jukema, J.W.; Willemsen, G.; Putter, H.; Slagboom, P.E.; Heijmans, B.T. Variation, patterns, and temporal stability of DNA methylation: Considerations for epigenetic epidemiology. FASEB J. 2010, 24, 3135-3144.
22. Ooi, S.K.; O'Donnell, A.H.; Bestor, T.H. Mammalian cytosine methylation at a glance. J. Cell Sci. 2009, 122, 2787-2791.
23. Das, R.; Dimitrova, N.; Xuan, Z.; Rollins, R.A.; Haghighi, F.; Edwards, J.R.; Ju, J.; Bestor, T.H.; Zhang, M.Q. Computational prediction of methylation status in human genomic sequences. Proc. Natl. Acad. Sci. USA 2006, 103, 10713-10716.
24. Rollins, R.A.; Haghighi, F.; Edwards, J.R.; Das, R.; Zhang, M.Q.; Ju, J.; Bestor, T.H. Large-scale structure of genomic methylation patterns. Genome Res. 2006, 16, 157-163.
25. Mikkelsen, T.S.; Ku, M.; Jaffe, D.B.; Issac, B.; Lieberman, E.; Giannoukos, G.; Alvarez, P.; Brockman, W.; Kim, T.K.; Koche, R.P.; et al. Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature 2007, 448, 553-560.
26. Kouzarides, T. Chromatin modifications and their function. Cell 2007, 128, 693-705.
27. Ropero, S.; Esteller, M. The role of histone deacetylases (HDACs) in human cancer. Mol. Oncol. 2007, 1, 19-25.
28. Iizuka, M.; Smith, M.M. Functional consequences of histone modifications. Curr. Opin. Genet. Dev. 2003, 13, 154-160.
29. Butler, J.S.; Koutelou, E.; Schibler, A.C.; Dent, S.Y. Histone-modifying enzymes: Regulators of developmental decisions and drivers of human disease. Epigenomics 2012, 4, 163-177.
30. Friedman, R.C.; Farh, K.K.; Burge, C.B.; Bartel, D.P. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 2009, 19, 92-105.
31. Londin, E.; Loher, P.; Telonis, A.G.; Quann, K.; Clark, P.; Jing, Y.; Hatzimichael, E.; Kirino, Y.; Honda, S.; Lally, M.; et al. Analysis of 13 cell types reveals evidence for the expression of numerous novel primate- and tissue-specific microRNAs. Proc. Natl. Acad. Sci. USA 2015, 112, E1106-E1115.
32. Denis, H.; Ndlovu, M.N.; Fuks, F. Regulation of mammalian DNA methyltransferases: A route to new mechanisms. EMBO Rep. 2011, 12, 647-656.
33. Waterland, R.A. Assessing the effects of high methionine intake on DNA methylation. J. Nutr. 2006, 136, 1706S-1710S.
34. Niculescu, M.D.; Zeisel, S.H. Diet, methyl donors and DNA methylation: Interactions between dietary folate, methionine and choline. J. Nutr. 2002, 132, 2333S-2335S.
35. Hardy, T.M.; Tollefsbol, T.O. Epigenetic diet: Impact on the epigenome and cancer. Epigenomics 2011, 3, 503-518.
36. Stone, N.; Pangilinan, F.; Molloy, A.M.; Shane, B.; Scott, J.M.; Ueland, P.M.; Mills, J.L.; Kirke, P.N.; Sethupathy, P.; Brody, L.C. Bioinformatic and genetic association analysis of microrna target sites in one-carbon metabolism genes. PLoS ONE 2011, 6, e21851.
37. Wolff, G.L.; Kodell, R.L.; Moore, S.R.; Cooney, C.A. Maternal epigenetics and methyl supplements affect agouti gene expression in Avy/a mice. FASEB J. 1998, 12, 949-957.
38. Cooney, C.A.; Dave, A.A.; Wolff, G.L. Maternal methyl supplements in mice affect epigenetic variation and DNA methylation of offspring. J. Nutr. 2002, 132, 2393S-2400S.
39. Waterland, R.A.; Jirtle, R.L. Transposable elements: Targets for early nutritional effects on epigenetic gene regulation. Mol Cell Biol 2003, 23, 5293-5300.
40. Waterland, R.A.; Travisano, M.; Tahiliani, K.G.; Rached, M.T.; Mirza, S. Methyl donor supplementation prevents transgenerational amplification of obesity. Int. J. Obes. (Lond.) 2008, 32, 1373-1379.
41. Cropley, J.E.; Suter, C.M.; Beckman, K.B.; Martin, D.I. Germ-line epigenetic modification of the murine Avy allele by nutritional supplementation. Proc. Natl. Acad. Sci. USA 2006, 103, 17308-17312.
42. Elango, N.; Hunt, B.G.; Goodisman, M.A.; Yi, S.V. DNA methylation is widespread and associated with differential gene expression in castes of the honeybee, Apis mellifera. Proc. Natl. Acad. Sci. USA 2009, 106, 11206-11211.
43. Hunt, B.G.; Brisson, J.A.; Yi, S.V.; Goodisman, M.A. Functional conservation of DNA methylation in the pea aphid and the honeybee. Genome Biol. Evol. 2010, 2, 719-728.
44. Ghoshal, K.; Li, X.; Datta, J.; Bai, S.; Pogribny, I.; Pogribny, M.; Huang, Y.; Young, D.; Jacob, S.T. A folate- and methyl-deficient diet alters the expression of DNA methyltransferases and methyl CpG binding proteins involved in epigenetic gene silencing in livers of F344 rats. J. Nutr. 2006, 136, 1522-1527.
45. Padmanabhan, N.; Jia, D.; Geary-Joo, C.; Wu, X.; Ferguson-Smith, A.C.; Fung, E.; Bieda, M.C.; Snyder, F.F.; Gravel, R.A.; Cross, J.C.; et al. Mutation in folate metabolism causes epigenetic instability and transgenerational effects on development. Cell 2013, 155, 81-93.
46. Pogribny, I.P.; Tryndyak, V.P.; Muskhelishvili, L.; Rusyn, I.; Ross, S.A. Methyl deficiency, alterations in global histone modifications, and carcinogenesis. J. Nutr. 2007, 137, 216S-222S.
47. Zhou, W.; Alonso, S.; Takai, D.; Lu, S.C.; Yamamoto, F.; Perucho, M.; Huang, S. Requirement of RIZ1 for cancer prevention by methyl-balanced diet. PLoS ONE 2008, 3, e3390.
48. Luka, Z.; Moss, F.; Loukachevitch, L.V.; Bornhop, D.J.; Wagner, C. Histone demethylase LSD1 is a folate-binding protein. Biochemistry 2011, 50, 4750-4756.
49. Franchina, T.; Amodeo, V.; Bronte, G.; Savio, G.; Ricciardi, G.R.; Picciotto, M.; Russo, A.; Giordano, A.; Adamo, V. Circulating miR-22, miR-24 and miR-34a as novel predictive biomarkers to pemetrexed-based chemotherapy in advanced non-small cell lung cancer. J. Cell Physiol. 2014, 229, 97-99.
50. Koturbash, I.; Melnyk, S.; James, S.J.; Beland, F.A.; Pogribny, I.P. Role of epigenetic and miR-22 and miR-29b alterations in the downregulation of Mat1a and Mthfr genes in early preneoplastic livers in rats induced by 2-acetylaminofluorene. Mol. Carcinog. 2013, 52, 318-327.
51. Novakovic, B.; Saffery, R. The ever growing complexity of placental epigenetics-Role in adverse pregnancy outcomes and fetal programming. Placenta 2012, 33, 959-970.
52. Yajnik, C.S.; Deshmukh, U.S. Fetal programming: Maternal nutrition and role of one-carbon metabolism. Rev. Endocr. Metab. Disord. 2012, 13, 121-127.
53. Longtine, M.S.; Nelson, D.M. Placental dysfunction and fetal programming: The importance of placental size, shape, histopathology, and molecular composition. Semin. Reprod. Med. 2011, 29, 187-196.
54. Fryer, A.A.; Nafee, T.M.; Ismail, K.M.; Carroll, W.D.; Emes, R.D.; Farrell, W.E. LINE-1 DNA methylation is inversely correlated with cord plasma homocysteine in man: A preliminary study. Epigenetics 2009, 4, 394-398.
55. Sinclair, K.D.; Lea, R.G.; Rees, W.D.; Young, L.E. The developmental origins of health and disease: Current theories and epigenetic mechanisms. Soc. Reprod. Fertil. Suppl. 2007, 64, 425-443.
56. Probst, A.V.; Dunleavy, E.; Almouzni, G. Epigenetic inheritance during the cell cycle. Nat. Rev. Mol. Cell Biol. 2009, 10, 192-206.
57. Jirtle, R.L.; Skinner, M.K. Environmental epigenomics and disease susceptibility. Nat. Rev. Genet. 2007, 8, 253-262.
58. Sinclair, K.D.; Singh, R. Modelling the developmental origins of health and disease in the early embryo. Theriogenology 2007, 67, 43-53.
59. Shenderov, B.A.; Midtvedt, T. Epigenomic programing: A future way to health? Microb. Ecol. Health Dis. 2014, 25, doi:10.3402/mehd.v25.24145.
60. Wilkinson, J. High maternal choline intake may prevent the development of stress-related disorders through epigenetic mechanisms. Epigenomics 2012, 4, 479-480.
61. Jiang, X.; Yan, J.; West, A.A.; Perry, C.A.; Malysheva, O.V.; Devapatla, S.; Pressman, E.; Vermeylen, F.; Caudill, M.A. Maternal choline intake alters the epigenetic state of fetal cortisol-regulating genes in humans. FASEB J. 2012, 26, 3563-3574.
62. Zeisel, S.H. Dietary choline deficiency causes DNA strand breaks and alters epigenetic marks on DNA and histones. Mutat. Res. 2012, 733, 34-38.
63. Oliva, J.; Bardag-Gorce, F.; Li, J.; French, B.A.; Nguyen, S.K.; Lu, S.C.; French, S.W. Betaine prevents Mallory-Denk body formation in drug-primed mice by epigenetic mechanisms. Exp. Mol. Pathol. 2009, 86, 77-86.
64. Wei, L.N. Non-canonical activity of retinoic acid in epigenetic control of embryonic stem cell. Transcription 2013, 4, doi:10.4161/trns.25395.
65. Cheong, H.S.; Lee, H.C.; Park, B.L.; Kim, H.; Jang, M.J.; Han, Y.M.; Kim, S.Y.; Kim, Y.S.; Shin, H.D. Epigenetic modification of retinoic acid-treated human embryonic stem cells. BMB Rep. 2010, 43, 830-835.
66. Loewy, A.D.; Niles, K.M.; Anastasio, N.; Watkins, D.; Lavoie, J.; Lerner-Ellis, J.P.; Pastinen, T.; Trasler, J.M.; Rosenblatt, D.S. Epigenetic modification of the gene for the vitamin B(12) chaperone MMACHC can result in increased tumorigenicity and methionine dependence. Mol. Genet. Metab. 2009, 96, 261-267.
67. Karlic, H.; Varga, F. Impact of vitamin D metabolism on clinical epigenetics. Clin. Epigenet. 2011, 2, 55-61.
68. Tian, X.; Diaz, F.J. Acute dietary zinc deficiency before conception compromises oocyte epigenetic programming and disrupts embryonic development. Dev. Biol. 2013, 376, 51-61.
69. Kurita, H.; Ohsako, S.; Hashimoto, S.; Yoshinaga, J.; Tohyama, C. Prenatal zinc deficiency-dependent epigenetic alterations of mouse metallothionein-2 gene. J. Nutr. Biochem. 2013, 24, 256-266.
70. Hu, Y.; McIntosh, G.H.; Le Leu, R.K.; Nyskohus, L.S.; Woodman, R.J.; Young, G.P. Combination of selenium and green tea improves the efficacy of chemoprevention in a rat colorectal cancer model by modulating genetic and epigenetic biomarkers. PLoS ONE 2013, 8, e64362.
71. Shankar, S.; Kumar, D.; Srivastava, R.K. Epigenetic modifications by dietary phytochemicals: Implications for personalized nutrition. Pharmacol. Ther. 2013, 138, 1-17.
72. Parasramka, M.A.; Ho, E.; Williams, D.E.; Dashwood, R.H. MicroRNAs, diet, and cancer: New mechanistic insights on the epigenetic actions of phytochemicals. Mol. Carcinog. 2012, 51, 213-230.
73. Lee, W.J.; Zhu, B.T. Inhibition of DNA methylation by caffeic acid and chlorogenic acid, two common catechol-containing coffee polyphenols. Carcinogenesis 2006, 27, 269-277.
74. Lambert, J.D.; Yang, C.S. Cancer chemopreventive activity and bioavailability of tea and tea polyphenols. Mutat. Res. 2003, 523, 201-208.
75. Wolfram, S.; Raederstorff, D.; Preller, M.; Wang, Y.; Teixeira, S.R.; Riegger, C.; Weber, P. Epigallocatechin gallate supplementation alleviates diabetes in rodents. J. Nutr. 2006, 136, 2512-2518.
76. Wolfram, S.; Wang, Y.; Thielecke, F. Anti-obesity effects of green tea: From bedside to bench. Mol. Nutr. Food Res. 2006, 50, 176-187.
77. Kopelovich, L.; Crowell, J.A.; Fay, J.R. The epigenome as a target for cancer chemoprevention. J. Natl. Cancer Inst. 2003, 95, 1747-1757.
78. Huang, J.; Plass, C.; Gerhauser, C. Cancer chemoprevention by targeting the epigenome. Curr. Drug Targets 2011, 12, 1925-1956.
79. Lu, H.; Meng, X.; Yang, C.S. Enzymology of methylation of tea catechins and inhibition of catechol-O-methyltransferase by (−)-epigallocatechin gallate. Drug Metab. Dispos. 2003, 31, 572-579.
80. Gerhauser, C. Cancer chemoprevention and nutriepigenetics: State of the art and future challenges. Top. Curr. Chem. 2013, 329, 73-132.
81. Liu, A.G.; Erdman, J.W., Jr. Lycopene and apo-10ʹ-lycopenal do not alter DNA methylation of GSTP1 in LNCaP cells. Biochem. Biophys. Res. Commun. 2011, 412, 479-482.
82. Yu, J.; Peng, Y.; Wu, L.C.; Xie, Z.; Deng, Y.; Hughes, T.; He, S.; Mo, X.; Chiu, M.; Wang, Q.E.; et al. Curcumin down-regulates DNA methyltransferase 1 and plays an anti-leukemic role in acute myeloid leukemia. PLoS ONE 2013, 8, e55934.
83. Vanhees, K.; Coort, S.; Ruijters, E.J.; Godschalk, R.W.; van Schooten, F.J.; Barjesteh van Waalwijk van Doorn-Khosrovani, S. Epigenetics: Prenatal exposure to genistein leaves a permanent signature on the hematopoietic lineage. FASEB J. 2011, 25, 797-807.
84. Hsu, A.; Wong, C.P.; Yu, Z.; Williams, D.E.; Dashwood, R.H.; Ho, E. Promoter de-methylation of Cyclin D2 by sulforaphane in prostate cancer cells. Clin. Epigenet. 2011, 3, doi:10.1186/1868-7083-3-3.
85. Wang, L.G.; Beklemisheva, A.; Liu, X.M.; Ferrari, A.C.; Feng, J.; Chiao, J.W. Dual action on promoter demethylation and chromatin by an isothiocyanate restored GSTP1 silenced in prostate cancer. Mol. Carcinog. 2007, 46, 24-31.
86. Stefanska, B.; Rudnicka, K.; Bednarek, A.; Fabianowska-Majewska, K. Hypomethylation and induction of retinoic acid receptor beta 2 by concurrent action of adenosine analogues and natural compounds in breast cancer cells. Eur. J. Pharmacol. 2010, 638, 47-53.
87. Link, A.; Balaguer, F.; Goel, A. Cancer chemoprevention by dietary polyphenols: Promising role for epigenetics. Biochem. Pharmacol. 2010, 80, 1771-1792.
88. Lee, Y.H.; Kwak, J.; Choi, H.K.; Choi, K.C.; Kim, S.; Lee, J.; Jun, W.; Park, H.J.; Yoon, H.G. EGCG suppresses prostate cancer cell growth modulating acetylation of androgen receptor by anti-histone acetyltransferase activity. Int. J. Mol. Med. 2012, 30, 69-74.
89. Lee, W.J.; Chen, Y.R.; Tseng, T.H. Quercetin induces FASL-related apoptosis, in part, through promotion of histone H3 acetylation in human leukemia HL-60 cells. Oncol. Rep. 2011, 25, 583-591.
90. Ross, S.A.; Davis, C.D. The emerging role of microRNAs and nutrition in modulating health and disease. Annu. Rev. Nutr. 2014, 34, 305-336.
91. Wang, Y.; Li, Y.; Liu, X.; Cho, W.C. Genetic and epigenetic studies for determining molecular targets of natural product anticancer agents. Curr. Cancer Drug Targets 2013, 13, 506-518.
92. Williams, S.R.; Yang, Q.; Chen, F.; Liu, X.; Keene, K.L.; Jacques, P.; Chen, W.M.; Weinstein, G.; Hsu, F.C.; Beiser, A.; et al. Genome-wide meta-analysis of homocysteine and methionine metabolism identifies five one carbon metabolism loci and a novel association of ALDH1L1 with ischemic stroke. PLoS Genet. 2014, 10, e1004214.
93. Shea, T.B.; Rogers, E. Lifetime requirement of the methionine cycle for neuronal development and maintenance. Curr. Opin. Psychiatry 2014, 27, 138-142.
94. Lillycrop, K.A.; Slater-Jefferies, J.L.; Hanson, M.A.; Godfrey, K.M.; Jackson, A.A.; Burdge, G.C. Induction of altered epigenetic regulation of the hepatic glucocorticoid receptor in the offspring of rats fed a protein-restricted diet during pregnancy suggests that reduced DNA methyltransferase-1 expression is involved in impaired DNA methylation and changes in histone modifications. Br. J. Nutr. 2007, 97, 1064-1073.
95. Sene Lde, B.; Mesquita, F.F.; de Moraes, L.N.; Santos, D.C.; Carvalho, R.; Gontijo, J.A.; Boer, P.A. Involvement of renal corpuscle microRNA expression on epithelial-to-mesenchymal transition in maternal low protein diet in adult programmed rats. PLoS ONE 2013, 8, e71310.
96. Gillberg, L.; Jacobsen, S.C.; Ronn, T.; Brons, C.; Vaag, A. PPARGC1A DNA methylation in subcutaneous adipose tissue in low birth weight subjects-Impact of 5 days of high-fat overfeeding. Metabolism 2014, 63, 263-271.
97. Langie, S.A.; Achterfeldt, S.; Gorniak, J.P.; Halley-Hogg, K.J.; Oxley, D.; van Schooten, F.J.; Godschalk, R.W.; McKay, J.A.; Mathers, J.C. Maternal folate depletion and high-fat feeding from weaning affects DNA methylation and DNA repair in brain of adult offspring. FASEB J. 2013, 27, 3323-3334.
98. Jacobsen, S.C.; Brons, C.; Bork-Jensen, J.; Ribel-Madsen, R.; Yang, B.; Lara, E.; Hall, E.; Calvanese, V.; Nilsson, E.; Jorgensen, S.W.; et al. Effects of short-term high-fat overfeeding on genome-wide DNA methylation in the skeletal muscle of healthy young men. Diabetologia 2012, 55, 3341-3349.
99. Gallou-Kabani, C.; Gabory, A.; Tost, J.; Karimi, M.; Mayeur, S.; Lesage, J.; Boudadi, E.; Gross, M.S.; Taurelle, J.; Vige, A.; et al. Sex- and diet-specific changes of imprinted gene expression and DNA methylation in mouse placenta under a high-fat diet. PLoS ONE 2010, 5, e14398.
100. Aagaard-Tillery, K.M.; Grove, K.; Bishop, J.; Ke, X.; Fu, Q.; McKnight, R.; Lane, R.H. Developmental origins of disease and determinants of chromatin structure: Maternal diet modifies the primate fetal epigenome. J. Mol. Endocrinol. 2008, 41, 91-102.
101. Cirera, S.; Birck, M.; Busk, P.K.; Fredholm, M. Expression profiles of miRNA-122 and its target cat1 in minipigs (Sus scrofa) fed a high-cholesterol diet. Comp. Med. 2010, 60, 136-141.
102. Takanabe, R.; Ono, K.; Abe, Y.; Takaya, T.; Horie, T.; Wada, H.; Kita, T.; Satoh, N.; Shimatsu, A.; Hasegawa, K. Up-regulated expression of microRNA-143 in association with obesity in adipose tissue of mice fed high-fat diet. Biochem. Biophys. Res. Commun. 2008, 376, 728-732.
103. Burdge, G.C.; Lillycrop, K.A. Fatty acids and epigenetics. Curr. Opin. Clin. Nutr. Metab. Care 2014, 17, 156-161.
104. Niculescu, M.D.; Craciunescu, C.N.; Zeisel, S.H. Dietary choline deficiency alters global and gene-specific DNA methylation in the developing hippocampus of mouse fetal brains. FASEB J. 2006, 20, 43-49.
105. Medici, V.; Shibata, N.M.; Kharbanda, K.K.; Islam, M.S.; Keen, C.L.; Kim, K.; Tillman, B.; French, S.W.; Halsted, C.H.; LaSalle, J.M. Maternal choline modifies fetal liver copper, gene expression, DNA methylation, and neonatal growth in the tx-j mouse model of Wilson disease. Epigenetics 2014, 9, 286-296.
106. Mehedint, M.G.; Niculescu, M.D.; Craciunescu, C.N.; Zeisel, S.H. Choline deficiency alters global histone methylation and epigenetic marking at the Re1 site of the calbindin 1 gene. FASEB J. 2010, 24, 184-195.
107. Wang, B.; Majumder, S.; Nuovo, G.; Kutay, H.; Volinia, S.; Patel, T.; Schmittgen, T.D.; Croce, C.; Ghoshal, K.; Jacob, S.T. Role of microRNA-155 at early stages of hepatocarcinogenesis induced by choline-deficient and amino acid-defined diet in C57BL/6 mice. Hepatology 2009, 50, 1152-1161.
108. Pellanda, H. Betaine homocysteine methyltransferase (BHMT)-dependent remethylation pathway in human healthy and tumoral liver. Clin. Chem. Lab. Med. 2013, 51, 617-621.
109. Li, M.; Cao, L.; Yang, Y. The role of epigenetic modification in glucose and lipid metabolism. Yi Chuan 2014, 36, 200-207.
110. Ferrari, A.; Fiorino, E.; Giudici, M.; Gilardi, F.; Galmozzi, A.; Mitro, N.; Cermenati, G.; Godio, C.; Caruso, D.; de Fabiani, E.; et al. Linking epigenetics to lipid metabolism: Focus on histone deacetylases. Mol. Membr. Biol. 2012, 29, 257-266.
111. El-Osta, A.; Brasacchio, D.; Yao, D.; Pocai, A.; Jones, P.L.; Roeder, R.G.; Cooper, M.E.; Brownlee, M. Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia. J. Exp. Med. 2008, 205, 2409-2417.
112. Mali, P.; Chou, B.K.; Yen, J.; Ye, Z.; Zou, J.; Dowey, S.; Brodsky, R.A.; Ohm, J.E.; Yu, W.; Baylin, S.B.; et al. Butyrate greatly enhances derivation of human induced pluripotent stem cells by promoting epigenetic remodeling and the expression of pluripotency-associated genes. Stem Cells 2010, 28, 713-720.
113. Martin, S.L.; Hardy, T.M.; Tollefsbol, T.O. Medicinal chemistry of the epigenetic diet and caloric restriction. Curr. Med. Chem. 2013, 20, 4050-4059.
114. Qiu, X.; Brown, K.V.; Moran, Y.; Chen, D. Sirtuin regulation in calorie restriction. Biochim. Biophys. Acta 2010, 1804, 1576-1583.
115. Ganguly, A.; Chen, Y.; Shin, B.C.; Devaskar, S.U. Prenatal caloric restriction enhances DNA methylation and MeCP2 recruitment with reduced murine placental glucose transporter isoform 3 expression. J. Nutr. Biochem. 2014, 25, 259-266.
116. Plagemann, A.; Harder, T.; Brunn, M.; Harder, A.; Roepke, K.; Wittrock-Staar, M.; Ziska, T.; Schellong, K.; Rodekamp, E.; Melchior, K.; et al. Hypothalamic proopiomelanocortin promoter methylation becomes altered by early overfeeding: An epigenetic model of obesity and the metabolic syndrome. J. Physiol. 2009, 587, 4963-4976.
117. Cho, C.E.; Sanchez-Hernandez, D.; Reza-Lopez, S.A.; Huot, P.S.; Kim, Y.I.; Anderson, G.H. High folate gestational and post-weaning diets alter hypothalamic feeding pathways by DNA methylation in Wistar rat offspring. Epigenetics 2013, 8, 710-719.
118. Ly, A.; Hoyt, L.; Crowell, J.; Kim, Y.I. Folate and DNA methylation. Antioxid. Redox Signal. 2012, 17, 302-326.
119. Crider, K.S.; Yang, T.P.; Berry, R.J.; Bailey, L.B. Folate and DNA methylation: A review of molecular mechanisms and the evidence for folate's role. Adv. Nutr. 2012, 3, 21-38.
120. Sinclair, K.D.; Allegrucci, C.; Singh, R.; Gardner, D.S.; Sebastian, S.; Bispham, J.; Thurston, A.; Huntley, J.F.; Rees, W.D.; Maloney, C.A.; et al. DNA methylation, insulin resistance, and blood pressure in offspring determined by maternal periconceptional B vitamin and methionine status. Proc. Natl. Acad. Sci. USA 2007, 104, 19351-19356.
121. Zhou, H.R.; Zhang, F.F.; Ma, Z.Y.; Huang, H.W.; Jiang, L.; Cai, T.; Zhu, J.K.; Zhang, C.; He, X.J. Folate polyglutamylation is involved in chromatin silencing by maintaining global DNA methylation and histone H3K9 dimethylation in Arabidopsis. Plant Cell 2013, 25, 2545-2559.
122. Xue, J.; Zempleni, J. Epigenetic synergies between biotin and folate in the regulation of pro-inflammatory cytokines and repeats. Scand. J. Immunol. 2013, 78, 419-425.
123. Pogribny, I.P.; Ross, S.A.; Tryndyak, V.P.; Pogribna, M.; Poirier, L.A.; Karpinets, T.V. Histone H3 lysine 9 and H4 lysine 20 trimethylation and the expression of Suv4-20h2 and Suv-39h1 histone methyltransferases in hepatocarcinogenesis induced by methyl deficiency in rats. Carcinogenesis 2006, 27, 1180-1186.
124. Tryndyak, V.P.; Ross, S.A.; Beland, F.A.; Pogribny, I.P. Down-regulation of the microRNAs miR-34a, miR-127, and miR-200b in rat liver during hepatocarcinogenesis induced by a methyl-deficient diet. Mol. Carcinog. 2009, 48, 479-487.
125. Pogribny, I.P.; Starlard-Davenport, A.; Tryndyak, V.P.; Han, T.; Ross, S.A.; Rusyn, I.; Beland, F.A. Difference in expression of hepatic microRNAs miR-29c, miR-34a, miR-155, and miR-200b is associated with strain-specific susceptibility to dietary nonalcoholic steatohepatitis in mice. Lab. Invest. 2010, 90, 1437-1446.
126. Minor, E.A.; Court, B.L.; Young, J.I.; Wang, G. Ascorbate induces ten-eleven translocation (Tet) methylcytosine dioxygenase-mediated generation of 5-hydroxymethylcytosine. J. Biol. Chem. 2013, 288, 13669-13674.
127. Moison, C.; Senamaud-Beaufort, C.; Fourriere, L.; Champion, C.; Ceccaldi, A.; Lacomme, S.; Daunay, A.; Tost, J.; Arimondo, P.B.; Guieysse-Peugeot, A.L. DNA methylation associated with polycomb repression in retinoic acid receptor beta silencing. FASEB J. 2013, 27, 1468-1478.
128. Kuriyama, M.; Udagawa, A.; Yoshimoto, S.; Ichinose, M.; Sato, K.; Yamazaki, K.; Matsuno, Y.; Shiota, K.; Mori, C. DNA methylation changes during cleft palate formation induced by retinoic acid in mice. Cleft Palate Craniofac. J. 2008, 45, 545-551.
129. Lee, E.R.; Murdoch, F.E.; Fritsch, M.K. High histone acetylation and decreased polycomb repressive complex 2 member levels regulate gene specific transcriptional changes during early embryonic stem cell differentiation induced by retinoic acid. Stem Cells 2007, 25, 2191-2199.
130. Urvalek, A.M.; Gudas, L.J. Retinoic acid and histone deacetylases regulate epigenetic changes in embryonic stem cells. J. Biol. Chem. 2014, 289, 19519-19530.
131. Urvalek, A.; Laursen, K.B.; Gudas, L.J. The roles of retinoic acid and retinoic acid receptors in inducing epigenetic changes. Subcell. Biochem. 2014, 70, 129-149.
132. Schenk, T.; Chen, W.C.; Gollner, S.; Howell, L.; Jin, L.; Hebestreit, K.; Klein, H.U.; Popescu, A.C.; Burnett, A.; Mills, K.; et al. Inhibition of the lsd1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemia. Nat. Med. 2012, 18, 605-611.
133. Das, S.; Foley, N.; Bryan, K.; Watters, K.M.; Bray, I.; Murphy, D.M.; Buckley, P.G.; Stallings, R.L. MicroRNA mediates DNA demethylation events triggered by retinoic acid during neuroblastoma cell differentiation. Cancer Res. 2010, 70, 7874-7881.
134. Hassan, Y.I.; Zempleni, J. Epigenetic regulation of chromatin structure and gene function by biotin. J. Nutr. 2006, 136, 1763-1765.
135. Huang, Y.; Khor, T.O.; Shu, L.; Saw, C.L.; Wu, T.Y.; Suh, N.; Yang, C.S.; Kong, A.N. A gamma-tocopherol-rich mixture of tocopherols maintains Nrf2 expression in prostate tumors of TRAMP mice via epigenetic inhibition of CpG methylation. J. Nutr. 2012, 142, 818-823.
136. Cornwell, D.G.; Ma, J. Studies in vitamin E: Biochemistry and molecular biology of tocopherol quinones. Vitam. Horm. 2007, 76, 99-134.
137. Bobrowska-Korczak, B.; Skrajnowska, D.; Tokarz, A. Effect of zinc and copper supplementation on the prognostic value of urinary 5-methyl-2'-deoxycytidine in DMBA-induced carcinogenesis in rats. Cancer Biomark. 2013, 13, 403-410.
138. Wang, L.; Bammler, T.K.; Beyer, R.P.; Gallagher, E.P. Copper-induced deregulation of microRNA expression in the zebrafish olfactory system. Environ. Sci. Technol. 2013, 47, 7466-7474.
139. Yang, G.; Zhu, Y.; Dong, X.; Duan, Z.; Niu, X.; Wei, J. TLT2-ICAM1-Gadd45alpha axis mediates the epigenetic effect of selenium on DNA methylation and gene expression in Keshan disease. Biol. Trace Elem. Res. 2014, 159, 69-80.
140. Metes-Kosik, N.; Luptak, I.; Dibello, P.M.; Handy, D.E.; Tang, S.S.; Zhi, H.; Qin, F.; Jacobsen, D.W.; Loscalzo, J.; Joseph, J. Both selenium deficiency and modest selenium supplementation lead to myocardial fibrosis in mice via effects on redox-methylation balance. Mol. Nutr. Food Res. 2012, 56, 1812-1824.
141. Szarc vel Szic, K.; Ndlovu, M.N.; Haegeman, G.; Vanden Berghe, W. Nature or nurture: Let food be your epigenetic medicine in chronic inflammatory disorders. Biochem. Pharmacol. 2010, 80, 1816-1832.
142. Khan, S.I.; Aumsuwan, P.; Khan, I.A.; Walker, L.A.; Dasmahapatra, A.K. Epigenetic events associated with breast cancer and their prevention by dietary components targeting the epigenome. Chem. Res. Toxicol. 2012, 25, 61-73.
143. Vanden Berghe, W. Epigenetic impact of dietary polyphenols in cancer chemoprevention: Lifelong remodeling of our epigenomes. Pharmacol. Res. 2012, 65, 565-576.
144. Ong, T.P.; Moreno, F.S.; Ross, S.A. Targeting the epigenome with bioactive food components for cancer prevention. J. Nutrigenet. Nutr. 2011, 4, 275-292.